Ignite Creation Date:
2025-12-24 @ 3:41 PM
Ignite Modification Date:
2026-01-16 @ 6:51 AM
Study NCT ID:
NCT03266692
Status:
TERMINATED
Last Update Posted:
2020-03-30
First Post:
2017-08-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma
Sponsor:
Cogent Biosciences, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-01
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-22
First Submit QC Date:
None
Study First Post Date:
2017-08-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-27
Last Update Post Date:
2020-03-30
Last Update Post Date Type:
ACTUAL